Previous Article | Next Article ![]()
J Virol, January 1998, p. 749-757, Vol. 72, No. 1
Unit of Molecular Pathology, Department of
Pathology, University Hospital Vrije Universiteit, 1081 HV Amsterdam,
The Netherlands,1 and
Department of
Biochemistry and Molecular Genetics, The University of Alabama at
Birmingham, Birmingham, Alabama 35294-00052
Received 18 June 1997/Accepted 3 October 1997
Organotypic cultures of human keratinocytes provide a useful model
system to study human papillomavirus (HPV)-host cell interactions. In
this study, we analyzed organotypic cultures of two HPV type 16 (HPV16)
(FK16A and FK16B)- and two HPV18 (FK18A and FK18B)-transfected keratinocyte cell lines through the process of immortalization in
vitro. For FK16A and FK18B cells, passages of both mortal cells in
their extended life span and subsequent immortal stages were studied.
Mortal cells of FK16A and FK18B showed a morphology reminiscent of mild
to moderate dysplasia, whereas in their immortal descendants, severely
dysplastic features were observed. Immortal FK18A cells were mildly to
moderately dysplastic, while FK16B cells were severely dysplastic. The
increasing degrees of dysplasia were associated with a decreasing
expression of differentiation markers cytokeratin 10 and profilaggrin.
All raft cultures expressed E6-E7 mRNAs in the basal layer, while the
amount of viral transcripts in the suprabasal cells was in general
proportional to the degree of dysplasia. In all cases, E6-E7
transcription and dysplastic features were highly correlated with
cellular proliferation, as assessed by Ki-67 (MIB-1) antigen
expression. Moreover, high levels of E6-E7 transcription and expression
of p21cip1 protein in the basal layer seemed to be mutually exclusive.
We conclude that expression of E6-E7 in the basal cells associated with
increased proliferation in the absence of detectable p21cip1 protein is
apparently necessary but not sufficient for immortalization, or for the
loss of terminal differentiation, for which yet to be discovered
additional events are required. The model system described in this
study provides a valuable tool to analyze alterations in viral
transcription regulation during HPV-mediated cell transformation.
Infections with mucosotropic human
papillomavirus (HPV) genotypes are related to the development of both
benign and malignant mucosal epithelial lesions (55).
Low-risk HPV types typically cause condylomata and papillomas, which
rarely undergo neoplastic progression, whereas infections with
high-risk HPV types, in particular HPV type 16 (HPV16) and HPV18, can
progress to high-grade dysplasias and invasive carcinomas. In benign
and low-grade lesions, the viral genome is maintained as
extrachromosomal plasmids in basal cell nuclei, while vegetative DNA
amplification occurs only in squamous epithelia undergoing terminal
differentiation. Usually, only very low levels of viral mRNA can be
detected in the infected basal cells, whereas viral transcription is
markedly increased in the differentiated layers (4, 15,
46-48). Moreover, expression of the viral genes is associated
with reactivation of the DNA replication machinery in the
differentiating spinous cells in condylomata and in low-grade
intraepithelial neoplasias (12, 13). This observation is
supported by retrovirus-mediated gene transfer, which shows that
expression of the high-risk or low-risk viral oncoprotein E7, which
inactivates the tumor suppressor protein pRB (49), under the
control of the native viral enhancer-promoter can induce proliferating
cell nuclear antigen (PCNA) in a differentiation-dependent manner in
primary keratinocytes grown as raft cultures. Furthermore, that the
high-risk HPV E7 alone can cause host DNA replication in these
differentiated cells (6). Therefore, it has been suggested that the natural function of the viral oncoprotein is to reactivate the
host DNA replication machinery, thereby facilitating viral DNA
replication in noncycling, differentiated cells. When expressed from a
constitutive promoter, the high-risk HPV E7 together with E6, which
inactivates another tumor suppressor protein p53 (28), can
immortalize primary human keratinocytes in culture (22, 34).
In addition, E7 specifically induces hyperproliferation of
keratinocytes both in vitro and in vivo (3, 9). It is evident that the epithelial raft culture of human keratinocytes that
are infected with recombinant retroviruses containing HPV sequences or
transfected with cloned viral DNA is a valuable tool for studying the
functions and regulation of HPV genes (2, 6, 18, 33) and
enhancer and promoter elements (37, 53; reviewed in
reference 8). The results correlate well with HPV infections in vivo. Thus organotypic cultures also provide a means for
studying alterations in the virus-host interactions which underlie
high-risk HPV-mediated transformation of epithelial cells.
We recently described a model system of HPV-mediated immortalization in
which two distinct stages were defined during monolayer culturing of
primary human foreskin keratinocytes transfected with HPV16 (cell lines
FK16A and FK16B) or HPV18 (cell lines FK18A and FK18B) (45).
The first stage was represented by cells that exhibited an extended but
still finite life span, whereas the second stage corresponded with
immortality. Transition from a mortal to an immortal stage has
previously been correlated with a strong telomerase activity,
postcrisis growth, or both. In cell lines FK16B and FK18B, mortal and
immortal stages were clearly demarcated by a period of crisis at
passages 13 and 20, respectively. No crisis period was observed in cell
lines FK16A and FK18A. Moreover, immortal stages of cell lines FK16A,
FK16B, and FK18B were marked by clonal allelic losses at one or more
chromosomal loci.
In this study, passages of these cell lines representing mortal and
immortal stages were cultured on collagen rafts and analyzed for
morphology, E6-E7 transcription, and the patterns of cellular proliferation and differentiation. Our results show that the different cell lines at these states are reminiscent of various degrees of
dysplasia, ranging from mild and moderate to severe dysplasia. However,
independent of their morphological appearance, all raft cultures
derived from mortal and immortal cells expressed E6-E7 mRNAs in the
basal layer, while the amount of viral transcripts in the suprabasal
cells was generally proportional to the degree of dysplasia. Moreover,
in all cases, diffused viral oncogene transcription was correlated with
dysplastic morphology and with cellular proliferation, as assessed by
Ki-67 (MIB-1) antigen expression (1), but inversely related
to expression of the universal cyclin-dependent kinase (CDK) inhibitor
p21cip1 (43).
Cell lines.
The cell lines FK16A, FK16B, FK18A, and FK18B
were established by transfection of primary human foreskin
keratinocytes (EK94-2) with the entire HPV16 and HPV18 genome
(45). Cells were grown in serum-free keratinocyte growth
medium (Life Technologies, Breda, The Netherlands) supplemented with
bovine pituitary extract (50 µg/ml), epidermal growth factor (5 ng/ml), penicillin (100U/ml), streptomycin (100 µg/ml), and
L-glutamine (2 mM) (Life Technologies).
Organotypic culture on collagen rafts.
Organotypic raft
cultures were prepared as described previously (29, 50),
with modifications (6, 37). For all four cell lines,
duplicate rafts were developed from each passage number. The dermal
equivalent contained Swiss 3T3 J2 fibroblasts (a gift from Elaine
Fuchs, University of Chicago, Chicago, Ill.). Briefly, raft culture
medium was modified from that of McCance et al. (32) and
contained Dulbecco modified Eagle medium-Ham's F-12 (3:1) supplemented with 10% fetal calf serum (Life Technologies, Bethesda, Md.), hydrocortisone (0.4 µg/ml), 0.1 nM cholera toxin, transferrin (5 µg/ml; Sigma), insulin (5 µg/ml; Sigma), and human epidermal growth factor (0.5 ng/ml; Life Technologies). Cultures were harvested after 9 days, fixed in 10% buffered formalin, and embedded in paraffin. Four-micrometer sections were stained with hematoxylin and
eosin for histological examination.
RNA in situ hybridization.
In situ hybridization with
35S-labeled riboprobes was carried out as described
previously (6, 13, 48). The sense- and antisense-strand
HPV16 E6-E7 (spanning nucleotides 24 to 654) and HPV18 E6-E7
(6) probes had a specific activity of 1.17 × 108 cpm/µg and were applied at 50 to 70% saturation.
After hybridization and a stringent wash at 63°C in 0.1× SSC (1×
SSC is 0.15 M NaCl plus 0.015 M sodium citrate), the sections were
dipped into Kodak NTE liquid emulsion and exposed for 7 days before
photographical development with D19. The slides were then photographed
under dark-field illumination, using an Olympus BH2 microscope equipped with a dark-field and bright-field dual condensor.
Immunohistochemical analysis.
Immunohistochemical staining
was performed on deparaffinized sections. Endogenous peroxidase was
inactivated by incubation with 0.3% H2O2 in
methanol for 30 min. The anti-cytokeratin 10 (K10) monoclonal antibody
(1:100 dilution; Biogenex, San Ramon, Calif.) and the
anti-profilaggrin/filaggrin antibody (1:100 dilution; Biomedical
Technologies, Stoughton, Mass.) were detected by using a histostain-SP
kit (Zymed Laboratories, South San Francisco, Calif.) in which
aminoethyl carbazole was used as the chromogen. To detect profilaggrin,
partial proteolytic digestion of tissue was performed with 0.1%
trypsin in phosphate-buffered saline (pH 7.2) for 10 min at 37°C
(50). For staining with monoclonal antibodies specific for
MIB-1 (Ki-67; 1:40 dilution; Dianova, Germany) and p21cip1 (1:500
dilution; Pharmingen, San Diego, Calif.), antigen retrieval was
performed by treating the slides in a 10 mM citrate buffer (pH 6.0) in
a microwave oven set at 800 W for 15 min. Sections were incubated with
primary antibodies at 4°C overnight, followed by incubation with a
biotinylated rabbit anti-mouse polyclonal antibody (diluted 1:500;
DAKO, Glostrup, Denmark). Antibody reactivity was detected by using a
peroxidase-conjugated streptavidin-biotin complex (sABC, diluted 1:200;
DAKO) and visualized by a 3-min reaction with diaminobenzidine (0.4 mg/ml; Sigma, St. Louis, Mo.)-0.002% H2O2 in
50 mM Tris-HCl (pH 7.6). The slides were counterstained lightly with
hematoxylin to reveal tissue morphology.
Raft cultures of HPV16- and HPV18-transfected keratinocytes display
a range of dysplastic changes during and following
immortalization.
Epithelial raft cultures were developed from the
primary donor keratinocytes (EK94-2) at passage 3 and from various
passages of the HPV16 (cell lines FK16A and FK16B)- and HPV18 (cell
lines FK18A and FK18B)-transfected descendants on a dermal equivalent containing mouse Swiss 3T3 J2 fibroblasts. Organotypic cultures of the
primary donor keratinocytes closely resembled normal epithelium in vivo
and contained morphologically distinct basal, spinous, granular, and
cornified layers (Fig. 1). Of the four
HPV- immortalized cell lines examined, mortal cells of FK16A and FK18B
in the extended life span were also analyzed. Raft cultures of mortal
FK16A cells at passages 17 and 20 showed abnormal differentiation,
characterized by the presence of stratified squamous layers that
resembled mild to moderate dysplasia in vivo (Fig.
2, FK16A p20). Cultures of the mortal
FK18B cells (passages 16 and 18) were also reminiscent of mild to
moderate dysplasia in vivo but appeared to be more differentiated than
FK16A cells (passages 17 and 20) (Fig. 3, FK18B p16). Raft cultures of the subsequent immortal stages of FK16A
(passage 81) and FK18B (passages 38 and 83) as well as immortal FK16B
(passage 63) showed a loss of morphological differentiation and a
histology consistent with severe dysplasia in vivo, characterized by
increased layers of basal-like cells and a loss of granular cells (Fig.
2, FK16A p81 and FK16B p63; Fig. 3, FK18B p83). In contrast, immortal
FK18A cells, at passages 27, 52, and 77, were all capable of terminal
differentiation and exhibited defined spinous and granular layers and
acellular squames (Fig. 3, FK18A p52); morphologically, no major
differences were observed among these three passages, and all resembled
mild dysplasia in vivo.
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Viral E6-E7 Transcription in the Basal Layer of
Organotypic Cultures without Apparent p21cip1 Protein Precedes
Immortalization of Human Papillomavirus Type 16- and 18-Transfected
Human Keratinocytes
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

View larger version (70K):
[in a new window]
FIG. 1.
Epithelial raft cultures of donor primary keratinocytes
(EK94-2). The same abbreviations are used in this figure and in Fig. 2
and 3. HE, hematoxylin-eosin staining; Immunohistochemical staining:
K10, cytokeratin 10 expression; PF, profilaggrin expression; p21,
p21cip1 protein expression; MIB, Ki-67 antigen expression.

View larger version (107K):
[in a new window]
FIG. 2.
Epithelial raft cultures of FK16A cells at passages 20 and 81 and FK16B cells at passage 63.

View larger version (103K):
[in a new window]
FIG. 3.
Epithelial raft cultures of FK18A cells at passage 52 and FK18B cells at passages 16 and 83.
Viral oncogene expression is closely correlated to cellular proliferation. To analyze viral oncogene expression, RNA in situ hybridization was performed with radiolabeled HPV16 E6-E7- and HPV18 E6-E7-specific antisense riboprobes. The specificity of both probes was confirmed by the absence of signals in raft cultures of HPV-negative primary keratinocytes (data not shown). In mortal FK16A cells (passages 17 and 20), the viral oncogenes were primarily expressed in the lower strata, up to the mid-spinous cell layers, and signals tended to reduce in the upper differentiated layers (Fig. 4, FK16A p20). Following immortalization, FK16A cells showed a sustained transcription in the basal layer with much reduced signals in the suprabasal layers, whereas transcription in immortalized FK16B cells was mostly basal, with moderate intensity in suprabasal cells (Fig. 4, FK16A p81 and FK16B p63). Mortal FK18B cells (at passages 16 and 18) showed diffused E6-E7 mRNA signals throughout the epithelium, with strongly positive cells scattered in both basal and parabasal layers (Fig. 5, FK18B p16). Immortal FK18B cells, at passages 38 and 83, exhibited diffused signals throughout the thickness of the epithelium (Fig. 5, FK18B p83). All passages of the well-differentiated FK18A cells revealed transcription of the viral oncogenes primarily in the basal and parabasal cells (Fig. 5, FK18A p52). Signals were greatly reduced in the spinous cells, but occasional spinous cells had strong signals.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
In vitro studies have revealed the capability of high-risk HPVs, by means of their transformation proteins E6 and E7, to induce immortalization of their natural target cells, the primary human epithelial cells (22, 34). This process, considered an important step toward malignancy, has been extensively studied and shown to require host gene alterations in addition to the expression of HPV oncoproteins (5, 42). To identify the genetic and cellular changes involved in this process, we developed an in vitro model system, using HPV16- and HPV18-transfected human foreskin keratinocytes, in which the transition from a mortal to an immortal phenotype has been well characterized (45). In monolayer cultures, both HPV16 and HPV18 initially induced an extended but still finite life span. At this stage, cells displayed a remarkable level of cytogenetic instability, manifested as numerical and structural chromosome alterations (44). This genome instability has similarly been reported in human dermal fibroblasts that have been transduced with HPV16 E6 and E7 genes and have an extended life span (52). However, these epithelial cells were devoid of any specific allelic losses or strong telomerase activity and exhibited telomere shortening upon passaging. In contrast, the immortal descendants have a strong telomerase activity accompanied by telomere restoration. Three of these cell lines, FK16A, FK16B, and FK18B, showed specific clonal allelic losses (45). In addition, the level of cytogenetic instability was comparable to that of their mortal ancestors (44).
Here, we have applied the organotypic culture system to study the characteristics of these cells at different passages before and after immortalization with respect to squamous differentiation, viral transcription, and cellular proliferation. All raft cultures transfected with either HPV16 or HPV18 presented various degrees of abnormal differentiation patterns with dysplastic features. In particular, raft cultures of FK16A (HPV16) or FK18B (HPV18) cells at the stage of extended life span already exhibited mild to moderate dysplastic characteristics. Therefore, it can be concluded that a disruption of the normal differentiation program can occur prior to immortalization. Although three of the cell lines (FK16A, FK16B, and FK18B) became severely dysplastic after immortalization, this progression in phenotype is not obligatory. This is best illustrated by FK18A cells, which maintained a mild dysplastic phenotype and the ability to undergo terminal differentiation even at or beyond passage 77 in the immortal state. Consequently, in vitro immortalization can be associated with a wide range of morphological changes, as has been shown by other groups as well (2, 32, 33, 51).
In warts and low-grade cervical lesions, E6-E7 transcription is tightly linked to terminal differentiation (4, 15, 47, 48). The fact that differentiated cells already have lost the ability to divide explains that immortalization and transformation do not invariably occur despite reactivation of host DNA replication (6). In contrast, high-grade lesions and cervical carcinomas often display elevated E6-E7 transcripts in the basal-like cells that occupy much or all of the epithelium (4, 15, 46). Hence, immortalization and transformation apparently require alterations affecting intracellular control mechanisms of HPV expression in the proliferating cell compartment (4, 54). Indeed, in situ hybridization analysis revealed that all passages of the cell lines that we examined actively transcribed E6-E7 genes in the basal proliferating cell layer, whereas E6-E7 transcription was down-regulated in the differentiated suprabasal cells. A similar down-regulation of viral oncogene expression during differentiation has also been observed upon implantation of HPV16-immortalized keratinocytes in nude mice (14). This pattern of expression is different from the differentiation-dependent expression in warts and in primary foreskin keratinocytes acutely infected with retroviruses in which the viral oncogenes are under the control of the homologous viral enhancer and promoter (6). Interestingly, mortal FK18B cells showed an E6-E7 transcriptional pattern suggesting the coexistence of both basal and differentiation-dependent expression. Therefore, these cells may represent an intermediate state between a productive infection and cell transformation. At late passages, immortal descendants of FK18B cells showing a severely dysplastic phenotype exhibited E6-E7 expression throughout the culture, resembling high-grade lesions in vivo. The distinction between primary foreskin keratinocytes and the HPV-transfected cell lines described here is not completely surprising given the fact that these latter cells were selected for proliferation in monolayer cultures, while keratinocytes that underwent terminal differentiation were lost during passage. Nevertheless, our data underscore the idea that up-regulation of E6-E7 transcription in proliferating cells is essential but not sufficient for immortalization and subsequent progression since the vast majority of mortal cells in their extended life span did not reach an immortal state. One caveat to these conclusions is that effects of other HPV genes that are also expressed cannot be excluded as these cell lines harbor the entire HPV genome.
Thus, an essential step during immortalization apparently includes an altered regulation of the viral enhancer-promoter in the basal layer, which might be conferred by a loss of repressor(s), a gain of activator(s), or both. In this aspect, viral DNA integration into the host chromosomes in the E1 or E2 gene, an event which occurs frequently in squamous carcinomas of the exocervix and in carcinomas in situ and carcinomas of the endocervix associated with HPV16 and HPV18 (10, 16, 46), has been suggested to be an important determinant resulting in the up-regulation of viral oncogene expression in the basal layer. Integration in the E1 or E2 gene eliminates the capability to express viral E2 proteins that can down-regulate the promoter for the viral oncogenes in cultured keratinocytes or epithelial cell lines (reviewed in reference 7). However, a recent study using the bacterial lacZ gene as a reporter showed that integrated viral enhancer-promoter is active only in the differentiated cells in raft cultures of primary foreskin keratinocytes even in the absence of E1 and E2 proteins (37, 53). Integration in the E1 or E2 gene necessitates the utilization of host polyadenylation sites for functional E6-E7 mRNAs. It has been shown that upon integration, the E6-E7 messages are greatly stabilized relative to those transcribed from extrachromosomal plasmids, conferring to these cells a growth advantage (26). However, it does not explain how viral oncogenes are up-regulated in dyplasias prior to integration, which is usually a late event in viral carcinogenesis. Mutations in the binding site for transcription factor YY1 located in the viral enhancer-promoter have been detected in cancers and were suggested to be a contributing factor (31). Lastly, integrated viral DNA might experience altered transcription regulation due to influences from local chromatin structures or enhancer elements present in the host DNA near the integration site. In the four cell lines examined in this study, stable integration of the viral DNA was demonstrated at the earliest passages analyzed (45). We believe that the up-regulation of E6 and E7 transcription in the basal cells is due to both a cis and a trans effect. The expression of the bacterial lacZ gene driven by the HPV18 or HPV11 upstream regulatory region in raft cultures of the FK18A cell line is also more prominent in the basal cells than in the upper, more differentiated strata, whereas it is expressed only in the differentiated upper spinous and lower granular layers in raft cultures of primary foreskin keratinocytes (37, 53). This difference signifies a trans effect on both endogenous viral genes and the exogenous transgene. In addition, there is a more dramatic difference in E6-E7 signals in the basal versus suprabasal cells compared to the lacZ expression in the same compartments (25). This observation suggests a cis effect on the expression of endogenous viral genes.
A significant increase in Ki-67 antigen-positive cells indicates that immortalization by high-risk HPV types is correlated with increased proliferation. A similar observation has been described for high-grade cervical dysplasias harboring high-risk HPV DNA (1, 24). Our data also show that cellular proliferation (Ki-67 positivity) was directly linked to viral E6-E7 transcription. However, it appeared that the extent of neither E6-E7 nor Ki-67 expression was directly correlated to immortality or the degree of dysplasia that these cells displayed in raft cultures.
p21cip1 protein expression has been found to be up-regulated in a variety of differentiated glandular tissues (36, 38). In the present study, raft cultures of primary keratinocytes showed very weak positivity for p21cip1 protein, primarily in some of the basal and occasionally parabasal cells, in agreement with our recent observations in vitro (27). This result can be contrasted to previous studies of adult cutaneous skin, where weak p21cip1 antibody reactivity was detected in suprabasal squamous cells (19, 23, 30, 38). Additionally, p21cip1 positivity was shown to be strongly induced in UV-irradiated skin, in psoriatic lesions, as well as in skin treated with irritants (23, 38). In another study, little p21cip1 protein was detectable in non-UV-irradiated normal skin, but upon UV irradiation, a marked induction was observed (17). The differences in the topographic distribution of cells demonstrating detectable p21cip1 protein levels among various studies may be due to differences in the body sites where the skin specimens were removed, to the developmental stage, or physiological state of the tissues. Neonatal foreskin has more growth potential than normal adult skin, especially when the cells are grown in raft culture media that promote rapid basal cell proliferation and when the cells also express the growth-promoting viral oncogenes. Studies of normal human fibroblasts and epithelial cells, in which p21cip1 protein expression was followed through the different phases of the cell cycle, found that p21cip1 was first up-regulated after addition of growth factors to growth-arrested cells. This was followed by a down-regulation as cells move into S phase. These studies suggested that p21cip1 was an immediate-early response gene to growth stimuli perhaps to prevent premature activation of CDKs (21, 35). Our detection of p21cip1 protein in raft cultures of untransfected donor primary foreskin keratinocytes only in the rapidly dividing basal cells is not inconsistent with this interpretation.
In the present study, p21cip1 protein was observed in the more differentiated upper cell layers in raft cultures of all passages of HPV16 or HPV18 DNA-transfected cells. Whether this induction represents a posttranscriptional response similar to that observed in benign lesions, papillomas, condylomata, mild and moderate dysplasias, and fully differentiated E7-transduced raft cultures remains to be determined (27, 41). Also remarkable is the observation that in contrast to the untransfected donor cells, no p21cip1 protein was detected in the basal cycling cells of any of the HPV-transfected cells. This loss of p21cip1 protein correlated with the high levels of viral oncogene transcription and, by inference, viral oncoprotein expression. Since the high-risk HPV E6 protein causes a rapid degradation of p53 (40), the absence of p21cip1 protein expression in the basal layers might indicate that the p53-dependent transcription activation of the p21cip1 gene which normally occurs in cycling cells was abrogated (43). This interpretation would be in agreement with a previous study of human fibroblasts expressing HPV16 E6 (52). Furthermore, the same study additionally showed that when both HPV16 E6 and E7 were expressed, p21cip1 protein was no longer associated with CDKs/cyclins. We hypothesize that a high level of HPV E6-E7 in the basal layer is an important event during HPV-mediated immortalization. In essence, when constitutively expressed in the basal cycling cells, E7 bypasses the cell cycle control by pRB, E6 eliminates the function of p53, and E6 and E7 together abrogate the function of p21cip1 protein, resulting in a loss of normal control of cell proliferation (52).
In conclusion, basal expression of E6-E7, resulting in an increased proliferation in the absence of p21cip1 protein expression, is a likely prerequisite for HPV-mediated cell transformation in vitro. However, although necessary, this phenomenon is apparently insufficient for immortalization and the loss of terminal differentiation. These observations support the hypothesis that additional events are required for the latter processes. To analyze whether this phenomenon also represents an important step during transformation of HPV-infected cells in vivo, biopsies of women showing progressive cervical intraepithelial neoplasias in a follow-up study of a cohort of women (39) are currently being analyzed for p21cip1 protein expression. Finally, our data show that a model system as described in this study provides a valuable tool to analyze alterations in viral transcription regulation during HPV-mediated cell transformation.
| |
ACKNOWLEDGMENTS |
|---|
We thank Henri Schrijnemakers, Ge Jin, and Liesbeth van der Raaij-Helmer for excellent technical assistance.
This work was supported by grants VU 93-605 and VU 96-1151 from the Dutch Cancer Society and by USPHS grants CA36200 and AI 34574. J.N.P. and S.I. were partially supported by training grants T32CA09467 and T32AI07493. The research of P.J.F.S. was made possible by a fellowship from the Royal Netherlands Academy of Arts and Sciences.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Dept. of Biochemistry and Molecular Genetics, The University of Alabama at Birmingham, 508 McCallum Basic Health Sciences Bldg., 1918 University Blvd., Birmingham, AL 35294-0005. Phone: (205) 975-8300. Fax: (205) 975-6075. E-mail: lchow{at}bmg.bhs.uab.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Al-Saleh, W., P. Delvenne, R. Greimers, V. Fridman, J. Doyen, and J. Boniver. 1995. Assessment of Ki-67 antigen immunostaining in squamous intraepithelial lesions of the uterine cervix. Anat. Pathol. 104:154-160. |
| 2. | Blanton, R. A., R. N. Perez, D. T. Merrick, and J. K. McDougall. 1991. Epithelial cells immortalized by human papillomaviruses have premalignant characteristics in organotypic culture. Am. J. Pathol. 138:673-685[Abstract]. |
| 3. | Blanton, R. A., M. D. Coltrera, A. M. Gown, C. L. Halbert, and J. K. McDougall. 1992. Expression of the HPV16 E7 gene generates proliferation in stratified squamous cell cultures which is independent of endogenous p53 levels. Cell Growth Differ. 3:791-802[Abstract]. |
| 4. | Broker, T. R., L. T. Chow, M. T. Chin, C. R. Rhodes, S. M. Wolinsky, A. Whitbeck, and M. H. Stoler. 1989. A molecular portrait of human papillomavirus carcinogenesis. Cancer Cells 7:197-208. |
| 5. |
Chen, T. M.,
G. Pecoraro, and V. Defendi.
1993.
Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells.
Cancer Res.
53:1167-1171 |
| 6. |
Cheng, S.,
D.-C. Schmidt-Grimminger,
T. Murant,
T. R. Broker, and L. T. Chow.
1995.
Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes.
Genes Dev.
9:2335-2349 |
| 7. | Chow, L. T., and T. R. Broker. 1996. Small DNA tumor viruses, p. 267-302. In N. Nathanson (ed.), Viral pathogenesis. Lippincott-Raven, Philadelphia, Pa. |
| 8. | Chow, L. T., and T. R. Broker. 1997. In vitro experimental systems for HPV: epithelial raft cultures for investigations of viral reproduction and pathogenesis and for genetic analyses of viral proteins and regulatory sequences. Clin. Dermatol. 15:217-227[Medline]. |
| 9. | Coussens, L. M., D. Hanahan, and J. M. Arbeit. 1996. Genetic predisposition and parameters of malignant progression in K14-HPV16 transgenic mice. Am. J. Pathol. 149:1899-1917[Abstract]. |
| 10. |
Cullen, A. P.,
R. Reid,
M. Campion, and A. T. Lörincz.
1991.
Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm.
J. Virol.
65:606-612 |
| 11. | Dale, B. A., K. A. Resing, and J. D. Lonsdale-Eccles. 1985. Filaggrin: a keratin filament associated protein. Ann. N. Y. Acad. Sci. 455:330-342[Medline]. |
| 12. | Demeter, L. M., M. H. Stoler, T. R. Broker, and L. T. Chow. 1994. Induction of proliferating cell nuclear antigen in differentiated keratinocytes of human papillomavirus-infected lesions. Hum. Pathol. 25:343-348[Medline]. |
| 13. |
Dollard, S. C.,
J. L. Wilson,
L. M. Demeter,
W. Bonnez,
R. C. Reichman,
T. R. Broker, and L. T. Chow.
1992.
Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures.
Genes Dev.
6:1131-1142 |
| 14. |
Dürst, M.,
F. X. Bosch,
D. Glitz,
A. Schneider, and H. zur Hausen.
1991.
Inverse relationship between human papillomavirus (HPV) type 16 early gene expression and cell differentiation in nude mouse epithelial cysts and tumors induced by HPV-positive human cell lines.
J. Virol.
65:796-804 |
| 15. | Dürst, M., D. Glitz, A. Schneider, and H. zur Hausen. 1992. Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridisation. Virology 189:132-140[Medline]. |
| 16. |
Dürst, M.,
A. Kleinheinz,
M. Holtz, and L. Gissmann.
1985.
The physical state of human papillomavirus type 16 DNA in benign and malignant tumors.
J. Gen. Virol.
66:1515-1522 |
| 17. |
El-Deiry, W. S.,
T. Tokino,
T. Waldman,
J. D. Oliner,
V. E. Velculescu,
M. Burrell,
D. E. Hill,
E. Healy,
J. L. Rees,
S. R. Hamilton,
K. W. Kinzler, and B. Vogelstein.
1995.
Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.
Cancer Res.
55:2910-2919 |
| 18. |
Frattini, M. G.,
H. B. Lim, and L. A. Laimins.
1996.
In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late gene expression.
Proc. Natl. Acad. Sci. USA
93:3062-3067 |
| 19. | Fredersdorf, S., A. W. Milne, P. A. Hall, and X. Lu. 1996. Characterization of a panel of novel anti-p21waf1/cip1 monoclonal antibodies and immunochemical analysis of p21waf1/cip1 expression in normal human tissues. Am. J. Pathol. 148:825-835[Abstract]. |
| 20. | Fuchs, E., A. L. Tyner, G. J. Giudice, D. Marchuk, A. RayChaudhury, and M. Rosenberg. 1987. The human keratin genes and their differential expression. Curr. Top. Dev. Biol. 22:5-34[Medline]. |
| 21. | Gudas, J., H. Nguyen, T. Li, D. Hill, and K. H. Cowan. 1995. Effects of cell cycle, wild-type p53 and DNA damage on p21cip1/waf1 expression in human breast epithelial cells. Oncogene 11:253-261[Medline]. |
| 22. | Hawley-Nelson, P., K. H. Vousden, N. L. Hubbert, D. R. Lowy, and J. T. Schiller. 1989. HPV 16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J. 8:3905-3910[Medline]. |
| 23. | Healy, E., N. J. Reynolds, M. D. Smith, D. Harrison, E. Doherty, C. Campbell, and J. L. Rees. 1995. Up-regulation of p21WAF1/CIP1 in psoriasis and after the application of irritants and tape stripping. J. Invest. Dermatol. 105:274-279[Medline]. |
| 24. |
Heselmeyer, K.,
E. Schrock,
S. du Manoir,
H. Blegen,
K. Shah,
R. Steinbeck,
G. Auer, and T. Ried.
1996.
Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix.
Proc. Natl. Acad. Sci. USA
93:479-484 |
| 25. | Isern, S., J. N. Parker, R. D. M. Steenbergen, P. J. F. Snijders, J. M. M. Walboomers, C. J. L. M. Meijer, T. R. Broker, and L. T. Chow. Unpublished data. |
| 26. |
Jeon, S., and P. F. Lambert.
1995.
Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis.
Proc. Natl. Acad. Sci. USA
92:1654-1658 |
| 27. | Jian, Y., D.-C. Schmidt-Grimminger, X. Wu, T. R. Broker, and L. T. Chow. Unpublished data. |
| 28. | Kastan, M. B., C. E. Canman, and C. J. Leonard. 1995. p53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev. 14:3-15[Medline]. |
| 29. |
Kopan, R.,
G. Traska, and E. Fuchs.
1987.
Retinoids as important regulators of terminal differentiation: examining keratin expression in individual epidermal cells at various states of keratinization.
J. Cell Biol.
105:427-440 |
| 30. | Matsuta, M., S. Kon, K. Sasaki, and M. Matsuta. 1997. Immunohistochemical detection of p21waf1/cip1 and p53 proteins in formalin-fixed paraffin-embedded tissue sections of squamous cell carcinoma of the skin. J. Dermatol. Sci. 14:233-239[Medline]. |
| 31. | May, M., X.-P. Dong, E. Beyer-Finkler, F. Stubenrauch, P. G. Fuchs, and H. Pfister. 1994. E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO J. 6:1460-1466. |
| 32. |
McCance, D. J.,
R. Kopan,
E. Fuchs, and L. A. Laimins.
1988.
Human papillomavirus type 16 alters human epithelial cell differentiation in vitro.
Proc. Natl. Acad. Sci. USA
85:7169-7173 |
| 33. | Merrick, D. T., A. M. Gown, C. L. Halbert, and J. K. McDougall. 1992. Altered expression of proliferation and differentiation markers in human papillomavirus 16 and 18 immortalized epithelial cells grown in organotypic culture. Am. J. Pathol. 140:167-177[Abstract]. |
| 34. |
Münger, K.,
W. C. Phelps,
V. Bubb,
P. M. Howley, and R. M. Schlegel.
1989.
The E6 and E7 genes of human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes.
J. Virol.
63:4417-4421 |
| 35. |
Nakanishi, M.,
G. R. Adami,
R. S. Robetorye,
A. Noda,
S. F. Venable,
D. Dimitrov,
O. M. Pereira-Smith, and J. R. Smith.
1995.
Exit from G0 and entry into the cell cycle of cells expressing p21sdi1 antisense RNA.
Proc. Natl. Acad. Sci. USA
92:4352-4356 |
| 36. | Palazzo, J. P., W. E. Mercer, A. J. Kovatich, and M. McHugh. 1997. Immunohistochemical localization of p21waf1/cip1 in normal, hyperplastic, and neoplastic uterine tissues. Hum. Pathol. 28:60-66[Medline]. |
| 37. | Parker, J. N., W. Zhao, K. J. Askins, T. R. Broker, and L. T. Chow. 1997. Mutational analyses of differentiation-dependent human papillomavirus type 18 enhancer elements in epithelial raft cultures of neonatal foreskin keratinocytes. Cell Growth Differ. 8:751-762[Abstract]. |
| 38. | Pontén, F., B. Berne, Z. P. Ren, M. Nister, and J. Ponten. 1995. Ultraviolet light induces expression of p53 and p21 in human skin: effect of sunscreen and constitutive p21 expression in skin appendages. J. Invest. Dermatol. 105:402-406[Medline]. |
| 39. | Remmink, A. J., J. M. M. Walboomers, T. J. M. Helmerhorst, F. J. Voorhorst, L. Rozendaal, E. K. J. Risse, C. J. L. M. Meijer, and P. Kenemans. 1995. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int. J. Cancer 61:306-311[Medline]. |
| 40. | Scheffner, M., H. Romanczuk, K. Münger, J. M. Huibregtse, J. A. Mietz, and P. M. Howley. 1994. Functions of human papillomavirus proteins. Curr. Top. Microbiol. Immunol. 186:83-99[Medline]. |
| 41. | Schmidt-Grimminger, D.-C., X. Wu, Y. Jian, T. R. Broker, and L. T. Chow. Post-transcriptional induction of p21cip1 protein in warts and dysplasias is inversely related to human papillomavirus activities. Am. J. Pathol., in press. |
| 42. |
Seagon, S., and M. Dürst.
1994.
Genetic analysis of an in vitro model system for human papillomavirus type 16-associated tumorigenesis.
Cancer Res.
54:5593-5598 |
| 43. |
Sherr, C. J., and J. M. Roberts.
1995.
Inhibitors of mammalian G1 cyclin-dependent kinases.
Genes Dev.
9:1149-1163 |
| 44. | Steenbergen, R. D. M., A. B. Oostra, H. Joenje, F. Arwert, J. M. M. Walboomers, C. J. L. M. Meijer, and P. J. F. Snijders. Cytogenetic instability following transfection of human keratinocytes with HPV 16 and HPV 18 DNA. Submitted for publication. |
| 45. | Steenbergen, R. D. M., J. M. M. Walboomers, C. J. L. M. Meijer, van der Raaij-Helmer, J. N. Parker, L. T. Chow, T. R. Broker, and P. J. F. Snijders. 1996. Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q. Oncogene 13:1249-1257[Medline]. |
| 46. | Stoler, M. H., C. R. Rhodes, A. Whitbeck, S. M. Wolinsky, L. T. Chow, and T. R. Broker. 1992. Human papillomavirus type 16 and 18 gene expression in cervical neoplasia. Hum. Pathol. 23:117-128[Medline]. |
| 47. |
Stoler, M. H.,
A. Whitbeck,
S. M. Wolinsky,
T. R. Broker,
L. T. Chow,
M. K. Howett, and J. W. Kreider.
1990.
Infectious cycle of human papillomavirus type 11 in human foreskin xenografts in nude mice.
J. Virol.
64:3310-3318 |
| 48. | Stoler, M. H., S. M. Wolinsky, A. Whitbeck, T. R. Broker, and L. T. Chow. 1989. Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes. Virology 172:331-340[Medline]. |
| 49. | Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330[Medline]. |
| 50. | Wilson, J. L., S. C. Dollard, L. T. Chow, and T. R. Broker. 1992. Epithelial specific gene expression during differentiation of stratified primary human keratinocyte cultures. Cell Growth Differ. 3:471-483[Abstract]. |
| 51. |
Woodworth, C. D.,
S. Waggoner,
W. Barnes,
M. H. Stoler, and J. A. DiPaolo.
1990.
Human cervical and foreskin epithelial cells immortalized by human papillomavirus DNAs exhibit dysplastic differentiation in vivo.
Cancer Res.
50:3709-3715 |
| 52. | Xiong, Y., D. Kuppuswamy, Y. Li, E. M. Livanos, M. Hixon, A. White, D. Beach, and T. D. Tlsty. 1996. Alteration of cell cycle kinase complexes in human papillomavirus E6- and E7-expressing fibroblasts precedes neoplastic transformation. J. Virol. 70:999-1008[Abstract]. |
| 53. | Zhao, W., L. T. Chow, and T. R. Broker. 1997. Transcription activities of human papillomavirus type 11 E6 promoter-proximal elements in raft and submerged cultures of foreskin keratinocytes. J. Virol. 71:8832-8840[Abstract]. |
| 54. | zur Hausen, H. 1994. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr. Top. Microbiol. Immunol. 186:131-156[Medline]. |
| 55. | zur Hausen, H., and E.-M. de Villiers. 1994. Human papillomaviruses. Annu. Rev. Microbiol. 48:427-447[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»